Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells.

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

Mir-4796 Enhances the Sensitivity of Breast Cancer Cells to Ionising Radiation by Impairing the DNA Repair Pathway.

Histone Methylation Can Either Promote or Reduce Cellular Radiosensitivity by Regulating DNA Repair Pathways

Chromatin Remodeling Modulates Radiosensitivity of the Daughter Cells Derived from Cell Population Exposed to Low- and High-Let Irradiation

Adaptive EGF Expression Sensitizes Pancreatic Cancer Cells to Ionizing Radiation Through Activation of the Cyclin D1/P53/PARP Pathway

Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer

DNA Methylation-Regulated HK1 Overexpression Contributes to Irradiation-Resistance by Promoting Glycolysis in Non-Small Cell Lung Cancer

The Pivotal Role of DNA Methylation in the Radio‐sensitivity of Tumor Radiotherapy

Ionizing Radiation Triggers Mitophagy to Enhance DNA Damage in Cancer Cells.

Dual-Epigenetically Relieving the MYC-Correlated Immunosuppression Via an Advanced Nano-Radiosensitizer Potentiates Cancer Immuno-Radiotherapy

Rapamycin-Induced Autophagy Sensitizes A549 Cells to Radiation Associated with Dna Damage Repair Inhibition

5-Azacytidine Enhances The Radiosensitivity Of Cne2 And Sune1 Cells In Vitro And In Vivo Possibly By Altering Dna Methylation

Research Advances in DNA Methylation and Radiosensitivity of Cancer Cells

HDAC-an important target for improving tumor radiotherapy resistance

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

MicroRNA-9 Enhanced Radiosensitivity and Its Mechanism of DNA Methylation in Non-Small Cell Lung Cancer

MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway.

Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

Epigenetics as a determinant of radiation response in cancer